Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/17/2011 | CA2816925A1 Nucleic acid-containing lipid particles and related methods |
11/17/2011 | CA2802671A1 Film compositions for delivery of actives |
11/17/2011 | CA2800577A1 Therapeutic liposomes and methods for producing and using the same |
11/17/2011 | CA2800497A1 Ratiometric combinatorial drug delivery |
11/17/2011 | CA2800315A1 Food compositions comprising organogels |
11/17/2011 | CA2799407A1 Alcohol-resistant oral pharmaceutical form |
11/17/2011 | CA2799204A1 Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt |
11/17/2011 | CA2799183A1 Therapeutic regimens |
11/17/2011 | CA2799110A1 Pharmaceutical dosage form comprising one or more antiretroviral active ingredients |
11/17/2011 | CA2798957A1 Lactoferrin-based biomaterials for tissue regeneration and drug delivery |
11/17/2011 | CA2798946A1 Darunavir compositions |
11/17/2011 | CA2798924A1 Improved methods for preparing squalene |
11/17/2011 | CA2798885A1 Combination of active loaded granules with additional actives |
11/17/2011 | CA2798884A1 Manufacturing of active-free granules and tablets comprising the same |
11/17/2011 | CA2798068A1 New dosage form for cineole |
11/17/2011 | CA2788526A1 Extended release formulations of desvenlafaxine base |
11/16/2011 | EP2386311A1 Compositions for improving lipid metabolism |
11/16/2011 | EP2386309A1 Bulbine frutescens gel |
11/16/2011 | EP2386308A1 Site-specific intestinal delivery of adsorbents, alone of in combination with degrading molecules |
11/16/2011 | EP2386302A1 A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof |
11/16/2011 | EP2386299A2 1-Amino-Alkylcyclohexane derivatives for the treatment of cochlear tinnitus |
11/16/2011 | EP2386297A1 Indigestible polymer: starch acetate -based film coatings for colon targeting |
11/16/2011 | EP2386296A2 New application forms for cineol |
11/16/2011 | EP2386295A2 Tablets with site time-controlled gastrointestinal release of active ingredients |
11/16/2011 | EP2386294A2 Unitary pharmaceutical dosage form comprising Tenofovir DF |
11/16/2011 | EP2386293A1 Process for producing a solid dispersion of an active ingredient |
11/16/2011 | EP2386292A1 Improvements relating to nanodispersions |
11/16/2011 | EP2386291A1 Vaginally administrable progesterone-containing tablets and method for preparing same |
11/16/2011 | EP2386290A2 Modulating drug release rate by controlling the kinetics of the pH transition in hydrogels |
11/16/2011 | EP2386289A1 Clay compositions |
11/16/2011 | EP2386269A2 Naltrexone long acting formulations and methods of use |
11/16/2011 | EP2385839A2 Therapeutic compositions for treatment of corneal disorders |
11/16/2011 | EP2385828A2 High-throughput production of ingestible event markers |
11/16/2011 | EP2385827A2 Pharmaceutical dosages delivery system |
11/16/2011 | EP2385826A2 Methods and materials for delivering bile acids |
11/16/2011 | EP2385825A1 Factor viii formulations |
11/16/2011 | EP2385824A2 Nanoparticle pharmaceutical formulations |
11/16/2011 | EP2385823A1 Dual release pharmaceutical suspension |
11/16/2011 | EP2385822A1 Pharmaceutical composition containing malathion and a volatile cyclic silicone |
11/16/2011 | EP2385821A1 Improved pharmaceutical formulation |
11/16/2011 | EP2385769A1 Rapidly dissolving vitamin formulation and methods of using the same |
11/16/2011 | EP2142170B1 A method of producing fast dissolving tablets |
11/16/2011 | EP2134326B1 Pharmaceutical compositions comprising irbesartan |
11/16/2011 | EP1948149B1 Formulation comprising metformin and vildagliptin |
11/16/2011 | EP1904038B1 Compressed pharmaceutical composition comprising coated pellets and a direct compression mixture, and method of preparation thereof |
11/16/2011 | EP1866007B1 System and method for loading a beneficial agent into a medical device |
11/16/2011 | EP1799194B1 A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
11/16/2011 | EP1633368B1 Foamable pharmaceutical compositions and methods for treating a disorder |
11/16/2011 | EP1549327B1 Composition for treating hemorrhoids |
11/16/2011 | EP1542657B1 Cannabinoid liquid formulations for mucosal amdinistration |
11/16/2011 | EP1392364B1 Liquid polymer composition for prevention and treatment of the oral cavity diseases |
11/16/2011 | CN202036555U Gynecological treatment suppository |
11/16/2011 | CN202036554U Oral mucoadhesive film preventing glue overflow |
11/16/2011 | CN1777415B Medicinal composition containing edible acid or its acid salt and its use |
11/16/2011 | CN1757637B Method for purifying VE nicotinate raw material |
11/16/2011 | CN1741791B A composition material for transmucosal delivery |
11/16/2011 | CN1733091B Finely prepared controlled release preparation for coronary disease and its preparation process |
11/16/2011 | CN1650846B Elemene liposome and its preparation method |
11/16/2011 | CN102245655A Modified polyvinyllactams |
11/16/2011 | CN102245590A Improved amino lipids and methods for the delivery of nucleic acids |
11/16/2011 | CN102245210A Octreotide depot formulation with constantly high exposure levels |
11/16/2011 | CN102245176A Fatty acids for use as a medicament |
11/16/2011 | CN102245173A Ulipristal acetate tablets |
11/16/2011 | CN102245172A Oral formulations containing metformin and a-glycosidase inhibitor, and preparation method thereof |
11/16/2011 | CN102245171A Slow-release particle and a production method therefor |
11/16/2011 | CN102245170A Process of cracking biofeeds using high zeolite to matrix surface area catalysts |
11/16/2011 | CN102245169A Salicylic acid composition |
11/16/2011 | CN102245168A Nanoparticle compositions |
11/16/2011 | CN102245167A Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
11/16/2011 | CN102245166A Ophthalmic administration of a composition including brimonidine as a mist |
11/16/2011 | CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof |
11/16/2011 | CN102241733A Deer ossein polypeptide chelated calcium and enteric capsule and preparation method of enteric capsule |
11/16/2011 | CN102240396A Application of multienzyme compound to prevention and treatment of fungus infection |
11/16/2011 | CN102240394A Use of interleukin-1receptor antagonist (IL-1Ra), and pharmaceutical compositions of IL-1Ra |
11/16/2011 | CN102240393A Injection preparation containing argatroban |
11/16/2011 | CN102240386A Traditional Chinese medicine preparation used for treating acute bronchitis, chronic bronchitis and bronchial asthma, and a preparation method thereof |
11/16/2011 | CN102240385A Traditional Chinese medicine dripping pill for treating woman postpartum disease and preparation method thereof |
11/16/2011 | CN102240358A Chinese medicinal blood fat removing and blood stasis eliminating mixture for treating hyperlipemia |
11/16/2011 | CN102240356A Powder for treating cervical spondylosis, intervertebral disc herniation, ankylosing spondylitis and hyperosteogeny |
11/16/2011 | CN102240350A Composition for treating gout and preparation method thereof |
11/16/2011 | CN102240348A Chinese medicine preparation Taohong pill for regulating menstruation and relieving pain |
11/16/2011 | CN102240347A Pharmaceutical composition for treating hyperuricemia and preparation method thereof |
11/16/2011 | CN102240346A Chinese medicine oral solution for treating infectious bursal disease of chicken |
11/16/2011 | CN102240344A Radix astragali capsule for treating cerebral ischemia |
11/16/2011 | CN102240342A Traditional Chinese medicine for treating viral hepatitis A |
11/16/2011 | CN102240325A Traditional Chinese medicine dispersible tablet for treating hepatitis, and preparation method thereof |
11/16/2011 | CN102240324A Compound medicament for treating dental ulcer |
11/16/2011 | CN102240322A Compound red sage root tablet and preparing process thereof |
11/16/2011 | CN102240320A Motherwort and astragalus capsule used for treating prostatic hyperplasia |
11/16/2011 | CN102240319A Potent gynaecologic detoxifying capsules and preparation method thereof |
11/16/2011 | CN102240318A Traditional Chinese medicine for tonifying qi and increasing breast milk |
11/16/2011 | CN102240303A Production method of composite probiotics for preventing and treating intestinal cancer |
11/16/2011 | CN102240299A Improved intravenously dripped multi-vitamin injection |
11/16/2011 | CN102240292A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
11/16/2011 | CN102240289A Pharmaceutical composition containing flibanserin polymorph a |
11/16/2011 | CN102240288A Application of N-substituted-3,5-dibenzal piperidine-4-one compounds |
11/16/2011 | CN102240285A Amoxicillin and potassium clavulanate tablet for dogs and cats, and its preparation method and application |
11/16/2011 | CN102240279A Piglet soothing agent and preparation method and application thereof |
11/16/2011 | CN102240277A Pharmaceutical composition for treating periodontitis, and preparation method and application thereof |
11/16/2011 | CN102240276A Granular preparation containing ambroxolhydrochloride and salbutamol sulfate and preparation method thereof |